These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 392560)

  • 41. On the nature of the radiobiologically hypoxic fraction in tumors.
    Sutherland RM; Franko AJ
    Int J Radiat Oncol Biol Phys; 1980 Jan; 6(1):117-20. PubMed ID: 6988374
    [No Abstract]   [Full Text] [Related]  

  • 42. [Recent data on biological and clinical properties of radiosensitizers (author's transl)].
    Guichard M; Malaise EP
    Pathol Biol (Paris); 1980 Jan; 28(1):29-42. PubMed ID: 6153787
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Combined radiosensitization and radioprotection for oral cavity tumors: study with an oral cavity tumor model.
    Grigsby P; Maruyama Y
    Int J Radiat Oncol Biol Phys; 1982; 8(3-4):557-9. PubMed ID: 6286553
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Structure-activity relationships for tumour radiosensitization by analogues of nicotinamide and benzamide.
    Brown JM; Lemmon MJ; Horsman MR; Lee WW
    Int J Radiat Biol; 1991 Mar; 59(3):739-48. PubMed ID: 1672362
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Radiosensitization by a new potent nucleoside analog: 1-(1',3',4'-trihydroxy-2'-butoxy)methyl-2-nitroimidazole(RP-343).
    Murayama C; Suzuki A; Sato C; Tanabe Y; Shoji T; Miyata Y; Nishio A; Suzuki T; Sakaguchi M; Mori T
    Int J Radiat Oncol Biol Phys; 1993 Jun; 26(3):433-43. PubMed ID: 8514541
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effect of environmental conditions (pH, oxygenation, and temperature) on misonidazole cytotoxicity and radiosensitization in vitro and in vivo in FSaIIC fibrosarcoma.
    Holden SA; Teicher BA; Herman TS
    Int J Radiat Oncol Biol Phys; 1991 May; 20(5):1031-8. PubMed ID: 2022503
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A new approach to the use of misonidazole as a radiosensitizer of hypoxic tumour cells.
    Abratt RP
    Br J Cancer; 1982 Dec; 46(6):976-9. PubMed ID: 7150492
    [No Abstract]   [Full Text] [Related]  

  • 48. The effect of misonidazole as a hypoxic radiosensitizer at low dose.
    Palcic B; Faddegon B; Skarsgard LD
    Radiat Res; 1984 Nov; 100(2):340-7. PubMed ID: 6494445
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Influence of misonidazole on the radiosensitivity of a human melanoma in nude mice: time-dependent increase in surviving fraction.
    Guichard M; de Langen-Omri F; Malaise EP
    Int J Radiat Oncol Biol Phys; 1979 Apr; 5(4):487-9. PubMed ID: 457494
    [No Abstract]   [Full Text] [Related]  

  • 50. SR-2508: a 2-nitroimidazole amide which should be superior to misonidazole as a radiosensitizer for clinical use.
    Brown JM; Yu NY; Brown DM; Lee WW
    Int J Radiat Oncol Biol Phys; 1981 Jun; 7(6):695-703. PubMed ID: 6457018
    [No Abstract]   [Full Text] [Related]  

  • 51. The effects of misonidazole during continuous low dose rate irradiation.
    Fu KK; Hurst S; Begg AC; Brown JM
    Cancer Clin Trials; 1980; 3(3):257-65. PubMed ID: 7438323
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Radiosensitizers: rationale and potential.
    Brown JM
    Cancer Treat Rep; 1981; 65 Suppl 2():95-102. PubMed ID: 7346152
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Radiosensitization by paclitaxel. The in-vivo results in paclitaxel-sensitive and -resistant tumors].
    Vogt HG; Zamboglou N
    Strahlenther Onkol; 1998 Oct; 174(10):539-40. PubMed ID: 9810324
    [No Abstract]   [Full Text] [Related]  

  • 54. Comparative studies of hypoxic-cell radiosensitization using artificially hypoxic skin in vivo.
    Denekamp J; Michael BD; Minchinton AI; Smithen CE; Stewart FA; Stratford MR; Terry NH
    Br J Cancer; 1982 Feb; 45(2):247-55. PubMed ID: 7059473
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Influence of misonidazole on the radiosensitivity of transplantable transitional cell bladder carcinoma in mice.
    Hampel N; Persky L
    Invest Urol; 1981 Jul; 19(1):14-6. PubMed ID: 7251317
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Testing of hypoxic cell radiosensitizers in vivo.
    Denekamp J
    Cancer Clin Trials; 1980; 3(2):139-48. PubMed ID: 7428137
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A comparison of radiosensitization by etanidazole and pimonidazole in mouse tumors.
    Stone HB; Hirst VK; Cribbs R; Luu YH; Brown JM
    Int J Radiat Oncol Biol Phys; 1991 May; 20(5):987-95. PubMed ID: 1827089
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Radiosensitization by misonidazole (Ro-07-0582) of fractionated X-rays in a murine tumour.
    Sheldon PW; Fowler JF
    Br J Cancer Suppl; 1978 Jun; 3():242-5. PubMed ID: 277239
    [TBL] [Abstract][Full Text] [Related]  

  • 59. On the additivity of hypoxic cell sensitizers in clinical practice.
    McNally NJ; de Ronde J
    Br J Radiol; 1979 Jul; 52(619):589-90. PubMed ID: 465950
    [No Abstract]   [Full Text] [Related]  

  • 60. In vitro and in vivo radiosensitization by 2-nitroimidazoles more electron-affinic than misonidazole.
    Brown DM; Yu NY; Brown JM; Lee WW
    Int J Radiat Oncol Biol Phys; 1982; 8(3-4):435-8. PubMed ID: 7107364
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.